Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 163-168

  Vegh, Agnes ^a   Györgyi, Kati ^a   Gy Papp, Julius ^a   Sakai, Kazushige ^a,c   Parratt, James R ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c Chughai Pharmaceutical Co Ltd   (Japan)

Author keywords

K(ATP) channel; myocardial ischemia; nicorandil; nitric oxide (NO); reperfusion; ventricular arrhythmia

Indexed keywords

NICORANDIL; NITRIC OXIDE DONOR; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG MECHANISM; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; INTRAARTERIAL DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

EID: 0342748381     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00166-5     Document Type: Article

References (21)

1. Billman, G.E., 1994, Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia, Cardiovasc. Res. 28, 762.
2. Black, S.C. and B.R. Lucchesi, 1994, Potassium channel openers are likely to be proarrhythmic in the diseased human heart, Cardiovasc. Res. 28, 923.
3. Chi, L., A.C.G. Uprichard and B.R. Lucchesi, 1990, Profibrillatory actions of pinacidil in a conscious canine model of sudden cardiac death, J. Cardiovasc. Pharmacol. 15, 452.
4. Coussaye de la, J.E., J.-J. Eldedjam and P. Bruelle, 1993, Electrophysiologic and arrhythmogenic effects of the potassium channel agonist BRL 38227 in anesthetized dogs, J. Cardiovasc. Pharmacol. 22, 722.
5. D'Alonzo, A.J. and G.J. Grover, 1994, Potassium channel openers are unlikely to be proarrhythmic in the diseased human heart, Cardiovasc. Res. 28, 924.
6. Fish, F.A., C. Prakesh and D.M. Roden, 1990, Suppression of repolarisation-related arrhythmias in vitro and in vivo by low-dose potassium channel activators, Circulation 82, 1362.
7. Gross, G.J., 1993, The cardioprotective effects of nicorandil, Rev. Contemp. Pharmacother. 4, 99.
8. Grover, G.J., 1994, Protective effects of ATP sensitive potassium channel openers in models of myocardial ischaemia, Cardiovasc. Res. 28, 778.
9. Holzmann, S., 1983, Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75), Cardiovasc. Pharmacol. 5, 364.
10. Kaszala, K., A. Vegh, J. Gy Papp, K. Gyorgy and J.R. Parratt, 1995, Local administration of potassium channel openers and ischaemia-induced ventricular arrhythmias, Br. J. Pharmacol. 114, 289P.
11. Kempsford, R.D. and B.J. Hawgood, 1989, Assessment of the antiarrhythmic activity of nicorandil during myocardial ischemia and reperfusion, Eur. J. Pharmacol. 163, 61.
12. Lathrop, D.A., B.P. Nanasi and A. Varro, 1990, In vitro cardiac models of dogs Purkinje fibres triggered and spontaneous electrical activity: effects of nicorandil, Br. J. Pharmacol. 99, 119.
13. Maulik, N., D.T. Engleman, M. Watanabe, R.M. Engleman, G. Maulik, G.A. Cordis and D.K. Das, 1995, Nitric oxide signalling in ischaemic heart, Cardiovasc. Res. 30, 593.
14. Neuss, H., 1993, The safety profile of nicorandil, Rev. Contemp. Pharmacother. 4, 221.
15. Pabla, R. and M.J. Curtis, 1995, Effects of NO modulation on cardiac arrhythmias in the rat isolated heart, Circ. Res. 77, 984.
16. Parratt, J.R., 1994, Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation, Trends Pharmacol. Sci. 15, 19.
17. Parratt, J.R. and A. Vegh, 1996, Endothelial cells, nitric oxide and ischaemic preconditioning, Basic Res. Cardiol. 91, 27.
18. Vegh, A., S. Komori, L. Szekeres and J.R. Parratt, 1992a, Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats, Cardiovasc. Res. 26, 487.
19. Vegh, A., J. Gy Papp, L. Szekeres and J.R. Parratt, 1992b, The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effects of ischaemic preconditioning, Br. J. Pharmacol. 107, 910.
20. Vegh, A., J. Gy Papp, L. Szekeres and J.R. Parratt, 1993, Are ATP sensitivie potassium channels involved in the pronounced antiarrhythmic effects of preconditioning?, Cardiovasc. Res. 27, 638.
21. Wilde, A.A.M., 1994, Proarrhythmic potential of the potassium channel openers, Cardiovasc. Res. 28, 928.